Home/Filings/4/0000905148-25-000977
4//SEC Filing

RODRIGUEZ RAUL R 4

Accession 0000905148-25-000977

CIK 0001034842other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:56 PM ET

Size

8.7 KB

Accession

0000905148-25-000977

Insider Transaction Report

Form 4
Period: 2025-03-17
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-17+30,00030,000 total
    Exercise: $12.70Exp: 2034-01-23Common Stock (30,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-03-17+26,25026,250 total
    Exercise: $35.40Exp: 2031-01-27Common Stock (26,250 underlying)
Footnotes (3)
  • [F1]The Reporting Person was granted a stock option with a performance-based condition with respect to 26,250 shares of the Issuer's common stock on January 27, 2021, as adjusted for the one-for-ten reverse stock split effective June 27, 2024 (the "Reverse Stock Split"). The exercise price of this option is $35.40, which is the closing price of the Issuer's common stock on Nasdaq on the date of grant, as adjusted for the Reverse Stock Split. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 17, 2025, it was determined that the performance metric had been met.
  • [F2]The option was fully vested on March 17, 2025, the date the determination was made that the performance metric had been met.
  • [F3]The Reporting Person was granted a stock option with a performance-based condition with respect to 30,000 shares of the Issuer's common stock on January 23, 2024, as adjusted for the Reverse Stock Split. The exercise price of this option is $12.70, which is the closing price of the Issuer's common stock on Nasdaq on the date of grant, as adjusted for the Reverse Stock Split. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 17, 2025, it was determined that the performance metric had been met.

Documents

1 file

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeother

Related Parties

1
  • filerCIK 0001190279

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:56 PM ET
Size
8.7 KB